Xenogeneic_JJ
human_JJ
serum_NN
promotes_VBZ
leukocyte_NN
adhesion_NN
to_TO
porcine_NN
endothelium_NN
under_IN
flow_NN
conditions_NNS
,_,
possibly_RB
through_IN
the_DT
activation_NN
of_IN
the_DT
transcription_NN
factor_NN
NF-kappa_NN
B_NN
._.

Endothelial_JJ
cell_NN
activation_NN
and_CC
leukocyte_NN
infiltration_NN
are_VBP
a_DT
consistent_JJ
feature_NN
of_IN
discordant_JJ
xenograft_NN
rejection_NN
._.

Here_RB
we_PRP
evaluated_VBD
whether_IN
xenogeneic_JJ
serum_NN
,_,
as_IN
a_DT
source_NN
of_IN
xenoreactive_JJ
natural_JJ
antibodies_NNS
and_CC
complement_NN
,_,
induced_VBD
endothelial_JJ
cell_NN
activation_NN
with_IN
consequent_JJ
leukocyte_NN
adhesion_NN
under_IN
flow_NN
conditions_NNS
._.

Porcine_JJ
aortic_JJ
endothelial_JJ
cells_NNS
-LRB-_-LRB-
PAEC_NNS
-RRB-_-RRB-
were_VBD
incubated_VBN
for_IN
1_CD
hr_NN
30_CD
min_NN
or_CC
5_CD
hr_NN
with_IN
10_CD
%_NN
homologous_JJ
porcine_NN
serum_NN
-LRB-_-LRB-
control_NN
-RRB-_-RRB-
or_CC
10_CD
%_NN
xenogeneic_JJ
human_JJ
serum_NN
and_CC
then_RB
perfused_VBN
with_IN
total_JJ
human_JJ
leukocytes_NNS
in_IN
a_DT
parallel_JJ
plate_NN
flow_NN
chamber_NN
under_IN
laminar_JJ
flow_NN
-LRB-_-LRB-
1.5_CD
dynes\/cm2_NNS
-RRB-_-RRB-
._.

Adherent_JJ
cells_NNS
were_VBD
counted_VBN
by_IN
digital_JJ
image_NN
analysis_NN
._.

Xenogeneic_JJ
human_JJ
serum_NN
significantly_RB
-LRB-_-LRB-
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
increased_VBD
the_DT
number_NN
of_IN
adherent_JJ
leukocytes_NNS
as_RB
compared_VBN
with_IN
porcine_NN
serum_NN
._.

A_DT
similar_JJ
adhesive_JJ
response_NN
was_VBD
elicited_VBN
by_IN
TNF_NN
alpha_NN
-LRB-_-LRB-
100_CD
U\/ml_NN
-RRB-_-RRB-
,_,
one_CD
of_IN
the_DT
most_JJS
potent_JJ
inducers_NNS
of_IN
endothelial_JJ
cell_NN
adhesive_JJ
properties_NNS
,_,
here_RB
used_VBN
as_IN
positive_JJ
control_NN
._.

In_IN
order_NN
to_TO
elucidate_VB
possible_JJ
mechanisms_NNS
underlying_VBG
endothelial_JJ
cell_NN
activation_NN
by_IN
xenogeneic_JJ
serum_NN
,_,
we_PRP
focussed_VBD
on_IN
transcription_NN
factor_NN
NF-kappa_NN
B_NN
,_,
a_DT
central_JJ
regulator_NN
for_IN
the_DT
induction_NN
of_IN
different_JJ
genes_NNS
,_,
including_VBG
adhesive_JJ
molecules_NNS
and_CC
chemoattractants_NNS
._.

By_IN
confocal_JJ
fluorescence_NN
microscopy_NN
,_,
we_PRP
observed_VBD
a_DT
positive_JJ
staining_NN
for_IN
NF-kappa_NN
B_NN
-LRB-_-LRB-
p65_NN
subunit_NN
-RRB-_-RRB-
in_IN
the_DT
nuclei_NNS
of_IN
PAEC_NNS
exposed_VBN
for_IN
1_CD
hr_NN
30_CD
min_NN
to_TO
human_JJ
serum_NN
,_,
which_WDT
indicated_VBD
NF-kappa_NN
B_NN
activation_NN
in_IN
this_DT
setting_NN
._.

At_IN
variance_NN
,_,
in_IN
PAEC_NNS
incubated_VBN
with_IN
the_DT
homologous_JJ
serum_NN
,_,
NF-kappa_NN
B_NN
was_VBD
strictly_RB
localized_JJ
in_IN
the_DT
cell_NN
cytoplasm_NN
._.

Treatment_NN
of_IN
PAEC_NNS
exposed_VBN
to_TO
xenogeneic_JJ
serum_NN
with_IN
the_DT
NF-kappa_NN
B_NN
inhibitors_NNS
pyrrolidinedithiocarbamate_NN
-LRB-_-LRB-
PDTC_NN
,_,
25_CD
microM_NN
-RRB-_-RRB-
and_CC
tosyl-phechloromethylketone_NN
-LRB-_-LRB-
TPCK_NN
,_,
25_CD
microM_NN
-RRB-_-RRB-
significantly_RB
-LRB-_-LRB-
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
reduced_VBD
leukocyte_NN
adhesion_NN
in_IN
respect_NN
to_TO
PAEC_NNS
treated_VBN
with_IN
human_JJ
serum_NN
alone_RB
._.

Findings_NNS
that_IN
xenogeneic_JJ
serum_NN
promotes_VBZ
leukocyte-endothelium_JJ
interaction_NN
possibly_RB
through_IN
NF-kappa_NN
B_NN
activation_NN
might_MD
be_VB
relevant_JJ
for_IN
designing_VBG
future_JJ
therapeutic_JJ
strategies_NNS
aimed_VBN
at_IN
prolonging_VBG
xenograft_NN
survival_NN
._.

